H35.149 Retinopathy of prematurity, stage 3, unspecified eye

Name of the Condition

• Retinopathy of prematurity, stage 3, unspecified eye

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 3 represents a more advanced phase where abnormal blood vessels grow and partially detach the retina. This stage carries a higher risk of progression to severe vision loss if untreated, requiring prompt evaluation and intervention. The unspecified eye designation indicates the condition is documented without specifying the right or left eye.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, with stage 3 reflecting significant retinal changes.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 3, ROP may not present obvious symptoms in infants. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the condition progresses.

Diagnosis

Diagnosis involves a comprehensive eye examination, typically performed by an ophthalmologist, using specialized equipment to assess retinal blood vessel development and detachment. Staging follows standardized criteria to determine the extent of retinal involvement.

Treatment Options

Treatment may include laser therapy or cryotherapy to halt abnormal vessel growth, or anti-VEGF medications in some cases. Close monitoring is essential to guide intervention timing and prevent progression.

Prognosis and Follow-Up

Prognosis depends on the severity of retinal detachment and response to treatment. Long-term follow-up is critical to monitor for vision changes, refractive errors, or late complications like retinal detachment.

Complications

Potential complications include retinal detachment, myopia, strabismus, amblyopia, or blindness if untreated. Premature infants with ROP require lifelong ophthalmologic surveillance.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful oxygen management and monitoring of preterm infants. No specific lifestyle modifications apply to infants, but parental education on follow-up care is essential.

When to Seek Professional Help

Seek immediate evaluation if signs of severe ROP (e.g., leukocoria, abnormal eye movements) are observed, or during routine neonatal eye screenings for preterm infants.

Tips for Medical Coders

Document the specific eye (right/left) when known; use "unspecified eye" only if the documentation does not specify. Ensure stage 3 is clearly documented, as it represents a distinct clinical phase requiring appropriate coding.